STERIS plc (STE) Valuation

Historical valuation analysis based on 500 data points (2024-08-30 to 2026-08-28)

Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring t...

STERIS plc (STE) currently trades at a P/E ratio of 36.73 (historical range: 31.49–89.83, median: 49.29), placing it at the 21th percentile — below its historical average, P/S ratio of 4.46 (range: 3.82–8.04, 23th percentile — below its historical average), EV/EBITDA of 24.95 (range: 21.58–205.12, 17th percentile).

Over the historical period (2024-08-30 to 2026-08-28), STERIS plc's P/E ratio has contracted by 35% over the observed period (from an average of 63.4 to 40.9).

STERIS plc appears significantly undervalued relative to its historical range, trading at depressed multiples across most metrics.

Historical Valuation Metrics

MetricCurrentMinMedianMaxPercentileAssessment
P/E Ratio36.7331.4949.2989.8321thbelow its historical average
P/S Ratio4.463.825.088.0423thbelow its historical average
EV/EBITDA24.9521.5842.68205.1217thcheap relative to its history
FCF Yield0.040.010.020.0482thcheap relative to its history
Current Price: $229.88
Market Cap: $22.4B
Sector: Healthcare